Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Nuclear Medicine Imaging Agents Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4689352
    • |
  • 27 April, 2026
    • |
  • Global
    • |
  • 118 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Nuclear Medicine Imaging Agents market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Nuclear Medicine Imaging Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Nuclear Medicine Imaging Agents market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Nuclear Medicine Imaging Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Nuclear Medicine Imaging Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Nuclear Medicine Imaging Agents market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nuclear Medicine Imaging Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nuclear Medicine Imaging Agents market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, Yantai Dongcheng, Foshan Rui Diao Pharmaceutical, Cardinal Health, Blue Earth Diagnostics, Bayer AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Nuclear Medicine Imaging Agents market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fluorine 18 Labeling
Carbon 11 Labeling
Nitrogen 13 Labeling
Oxygen 15 Labeling
Technetium 99 Labeling
Others
Market segment by Application
Early Diagnosis
Clinical Stage
Treatment Evaluation
Major players covered
GE HealthCare
Bracco Diagnostic
Guerbet
Mallinckrodt
Lantheus
Yantai Dongcheng
Foshan Rui Diao Pharmaceutical
Cardinal Health
Blue Earth Diagnostics
Bayer AG
Abx Advanced Biochemical
Eli Lilly and Company
Jubilant Pharma Limited
Navidea
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Medicine Imaging Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nuclear Medicine Imaging Agents, with price, sales quantity, revenue, and global market share of Nuclear Medicine Imaging Agents from 2021 to 2026.
Chapter 3, the Nuclear Medicine Imaging Agents competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medicine Imaging Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Nuclear Medicine Imaging Agents market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nuclear Medicine Imaging Agents.
Chapter 14 and 15, to describe Nuclear Medicine Imaging Agents sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Nuclear Medicine Imaging Agents Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Fluorine 18 Labeling
    • 1.3.3 Carbon 11 Labeling
    • 1.3.4 Nitrogen 13 Labeling
    • 1.3.5 Oxygen 15 Labeling
    • 1.3.6 Technetium 99 Labeling
    • 1.3.7 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Nuclear Medicine Imaging Agents Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Early Diagnosis
    • 1.4.3 Clinical Stage
    • 1.4.4 Treatment Evaluation
  • 1.5 Global Nuclear Medicine Imaging Agents Market Size & Forecast
    • 1.5.1 Global Nuclear Medicine Imaging Agents Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Nuclear Medicine Imaging Agents Sales Quantity (2021-2032)
    • 1.5.3 Global Nuclear Medicine Imaging Agents Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 GE HealthCare
    • 2.1.1 GE HealthCare Details
    • 2.1.2 GE HealthCare Major Business
    • 2.1.3 GE HealthCare Nuclear Medicine Imaging Agents Product and Services
    • 2.1.4 GE HealthCare Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 GE HealthCare Recent Developments/Updates
  • 2.2 Bracco Diagnostic
    • 2.2.1 Bracco Diagnostic Details
    • 2.2.2 Bracco Diagnostic Major Business
    • 2.2.3 Bracco Diagnostic Nuclear Medicine Imaging Agents Product and Services
    • 2.2.4 Bracco Diagnostic Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Bracco Diagnostic Recent Developments/Updates
  • 2.3 Guerbet
    • 2.3.1 Guerbet Details
    • 2.3.2 Guerbet Major Business
    • 2.3.3 Guerbet Nuclear Medicine Imaging Agents Product and Services
    • 2.3.4 Guerbet Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Guerbet Recent Developments/Updates
  • 2.4 Mallinckrodt
    • 2.4.1 Mallinckrodt Details
    • 2.4.2 Mallinckrodt Major Business
    • 2.4.3 Mallinckrodt Nuclear Medicine Imaging Agents Product and Services
    • 2.4.4 Mallinckrodt Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Mallinckrodt Recent Developments/Updates
  • 2.5 Lantheus
    • 2.5.1 Lantheus Details
    • 2.5.2 Lantheus Major Business
    • 2.5.3 Lantheus Nuclear Medicine Imaging Agents Product and Services
    • 2.5.4 Lantheus Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Lantheus Recent Developments/Updates
  • 2.6 Yantai Dongcheng
    • 2.6.1 Yantai Dongcheng Details
    • 2.6.2 Yantai Dongcheng Major Business
    • 2.6.3 Yantai Dongcheng Nuclear Medicine Imaging Agents Product and Services
    • 2.6.4 Yantai Dongcheng Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Yantai Dongcheng Recent Developments/Updates
  • 2.7 Foshan Rui Diao Pharmaceutical
    • 2.7.1 Foshan Rui Diao Pharmaceutical Details
    • 2.7.2 Foshan Rui Diao Pharmaceutical Major Business
    • 2.7.3 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product and Services
    • 2.7.4 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Foshan Rui Diao Pharmaceutical Recent Developments/Updates
  • 2.8 Cardinal Health
    • 2.8.1 Cardinal Health Details
    • 2.8.2 Cardinal Health Major Business
    • 2.8.3 Cardinal Health Nuclear Medicine Imaging Agents Product and Services
    • 2.8.4 Cardinal Health Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Cardinal Health Recent Developments/Updates
  • 2.9 Blue Earth Diagnostics
    • 2.9.1 Blue Earth Diagnostics Details
    • 2.9.2 Blue Earth Diagnostics Major Business
    • 2.9.3 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product and Services
    • 2.9.4 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Blue Earth Diagnostics Recent Developments/Updates
  • 2.10 Bayer AG
    • 2.10.1 Bayer AG Details
    • 2.10.2 Bayer AG Major Business
    • 2.10.3 Bayer AG Nuclear Medicine Imaging Agents Product and Services
    • 2.10.4 Bayer AG Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Bayer AG Recent Developments/Updates
  • 2.11 Abx Advanced Biochemical
    • 2.11.1 Abx Advanced Biochemical Details
    • 2.11.2 Abx Advanced Biochemical Major Business
    • 2.11.3 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product and Services
    • 2.11.4 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Abx Advanced Biochemical Recent Developments/Updates
  • 2.12 Eli Lilly and Company
    • 2.12.1 Eli Lilly and Company Details
    • 2.12.2 Eli Lilly and Company Major Business
    • 2.12.3 Eli Lilly and Company Nuclear Medicine Imaging Agents Product and Services
    • 2.12.4 Eli Lilly and Company Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Eli Lilly and Company Recent Developments/Updates
  • 2.13 Jubilant Pharma Limited
    • 2.13.1 Jubilant Pharma Limited Details
    • 2.13.2 Jubilant Pharma Limited Major Business
    • 2.13.3 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product and Services
    • 2.13.4 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Jubilant Pharma Limited Recent Developments/Updates
  • 2.14 Navidea
    • 2.14.1 Navidea Details
    • 2.14.2 Navidea Major Business
    • 2.14.3 Navidea Nuclear Medicine Imaging Agents Product and Services
    • 2.14.4 Navidea Nuclear Medicine Imaging Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Navidea Recent Developments/Updates

3 Competitive Environment: Nuclear Medicine Imaging Agents by Manufacturer

  • 3.1 Global Nuclear Medicine Imaging Agents Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Nuclear Medicine Imaging Agents Revenue by Manufacturer (2021-2026)
  • 3.3 Global Nuclear Medicine Imaging Agents Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Nuclear Medicine Imaging Agents by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Nuclear Medicine Imaging Agents Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Nuclear Medicine Imaging Agents Manufacturer Market Share in 2025
  • 3.5 Nuclear Medicine Imaging Agents Market: Overall Company Footprint Analysis
    • 3.5.1 Nuclear Medicine Imaging Agents Market: Region Footprint
    • 3.5.2 Nuclear Medicine Imaging Agents Market: Company Product Type Footprint
    • 3.5.3 Nuclear Medicine Imaging Agents Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Nuclear Medicine Imaging Agents Market Size by Region
    • 4.1.1 Global Nuclear Medicine Imaging Agents Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Nuclear Medicine Imaging Agents Consumption Value by Region (2021-2032)
    • 4.1.3 Global Nuclear Medicine Imaging Agents Average Price by Region (2021-2032)
  • 4.2 North America Nuclear Medicine Imaging Agents Consumption Value (2021-2032)
  • 4.3 Europe Nuclear Medicine Imaging Agents Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Nuclear Medicine Imaging Agents Consumption Value (2021-2032)
  • 4.5 South America Nuclear Medicine Imaging Agents Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Nuclear Medicine Imaging Agents Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Nuclear Medicine Imaging Agents Sales Quantity by Type (2021-2032)
  • 5.2 Global Nuclear Medicine Imaging Agents Consumption Value by Type (2021-2032)
  • 5.3 Global Nuclear Medicine Imaging Agents Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Nuclear Medicine Imaging Agents Sales Quantity by Application (2021-2032)
  • 6.2 Global Nuclear Medicine Imaging Agents Consumption Value by Application (2021-2032)
  • 6.3 Global Nuclear Medicine Imaging Agents Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Nuclear Medicine Imaging Agents Sales Quantity by Type (2021-2032)
  • 7.2 North America Nuclear Medicine Imaging Agents Sales Quantity by Application (2021-2032)
  • 7.3 North America Nuclear Medicine Imaging Agents Market Size by Country
    • 7.3.1 North America Nuclear Medicine Imaging Agents Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Nuclear Medicine Imaging Agents Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Nuclear Medicine Imaging Agents Sales Quantity by Type (2021-2032)
  • 8.2 Europe Nuclear Medicine Imaging Agents Sales Quantity by Application (2021-2032)
  • 8.3 Europe Nuclear Medicine Imaging Agents Market Size by Country
    • 8.3.1 Europe Nuclear Medicine Imaging Agents Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Nuclear Medicine Imaging Agents Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Nuclear Medicine Imaging Agents Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Nuclear Medicine Imaging Agents Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Nuclear Medicine Imaging Agents Market Size by Region
    • 9.3.1 Asia-Pacific Nuclear Medicine Imaging Agents Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Nuclear Medicine Imaging Agents Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Nuclear Medicine Imaging Agents Sales Quantity by Type (2021-2032)
  • 10.2 South America Nuclear Medicine Imaging Agents Sales Quantity by Application (2021-2032)
  • 10.3 South America Nuclear Medicine Imaging Agents Market Size by Country
    • 10.3.1 South America Nuclear Medicine Imaging Agents Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Nuclear Medicine Imaging Agents Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Nuclear Medicine Imaging Agents Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Nuclear Medicine Imaging Agents Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Nuclear Medicine Imaging Agents Market Size by Country
    • 11.3.1 Middle East & Africa Nuclear Medicine Imaging Agents Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Nuclear Medicine Imaging Agents Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Nuclear Medicine Imaging Agents Market Drivers
  • 12.2 Nuclear Medicine Imaging Agents Market Restraints
  • 12.3 Nuclear Medicine Imaging Agents Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Nuclear Medicine Imaging Agents and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Nuclear Medicine Imaging Agents
  • 13.3 Nuclear Medicine Imaging Agents Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Nuclear Medicine Imaging Agents Typical Distributors
  • 14.3 Nuclear Medicine Imaging Agents Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Nuclear Medicine Imaging Agents. Industry analysis & Market Report on Nuclear Medicine Imaging Agents is a syndicated market report, published as Global Nuclear Medicine Imaging Agents Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Nuclear Medicine Imaging Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo